BioSpace News Archive

AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and COVID-19 research, announced today the development, patent filing and Emergency Use Approval (EUA) filing of NeuCovix-HT™, a high throughput (HT) patent-pending diagnostic test that measures levels of functional antibodies in plasma or serum that neutralize SARS-CoV-2, the virus that caus

CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, announced today that its ePoster featuring new antifibrotic data is now available to registered attendees of the American Thoracic Society’s Virtual 2020 Conference, being held August 5 to 10, 2020. The ePoster presents data on CohBar’s MBT2 (CB5138-1), which is an analog of a

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that following the U.S. Food & Drug Administration (“U.S. FDA”) approval to proceed with the Company’s Phase 3 clinical trial to evaluate the safety and efficacy of Bucillamine in patients with mild-moderate COVID-19, the C

The Lupus Research Alliance announced that its 2020 Lupus Insight Prize will go to Jane Salmon, MD for her work in improving the health of pregnant women with lupus and antiphospholipid syndrome.

Clinical evaluation of PEC-Encap has resumed using sentinels created with the novel membrane; preclinical and initial clinical data suggest the novel membrane can mitigate the foreign body host response [05-August-2020] SAN DIEGO and NEWARK, Del. , August 5, 2020 /PRNewswire/ -- ViaCyte, Inc. , a clinical stage regenerative medicine company, and W. L. Gore & As

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that it has appointed Dr. Dana Ben-Ami Shor to its Scientific Board of Advisors.

Rising Biosciences, Inc. (OTC PINK:RBII) CEO Arthur Hall said that as the large disinfectant manufacturers are reporting supply chain problems, RBII has no similar issues and is meeting customers needs. Other larger companies have reported their supply chains are stressed said Hall.

Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biotechnology company targeting cancers caused by dysregulated gene expression, announced that the Company will host a conference call and live audio webcast on Wednesday, August 12, 2020, at 4:30 p.m. ET, to discuss its corporate and financial results for the second quarter 2020. Conference Call Information: Interested participants and investors may access the conference call by

BehaVR , a leading innovator of virtual reality digital wellness and digital therapeutics experiences, today announced that it has begun a new partnership aimed at leveraging virtual reality experienc

Generation Bio Co., an innovative genetic medicines company creating a new class of non-viral gene therapy, announced that management will present at the 2020 Wedbush PacGrow Healthcare Virtual Conference on Wednesday, Aug. 12, 2020 at 10:20 a.m. ET.